Skip to main content

Table 4 Lengths of hospital and ICU stays and cost of hospitalizations in the intervention and control periods (mITT population)

From: Active surveillance testing to reduce transmission of carbapenem-resistant, gram-negative bacteria in intensive care units: a pragmatic, randomized cross-over trial

Ā 

Intervention period (nā€‰=ā€‰590)

Control period (nā€‰=ā€‰724)

P value

Length of hospital stay, mean (Ā±ā€‰SE) days

44.7 (1.9)

45.6 (1.9)

0.73

Length of ICU stay, mean (Ā±ā€‰SE) days

11.0 (0.5)

11.2 (0.5)

0.73

Cost of hospitalization ($), mean (Ā±ā€‰SE)

93,491 (6034)

87,825 (4,252)

0.43